CRISPR
Trade CRISPR 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CRSP
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.
CRSP Key Statistics
Stock Snapshot
The current CRISPR(CRSP) stock price is $52.57, with a market capitalization of 5.01B. The stock trades at a price-to-earnings (P/E) ratio of -9.41.
During the trading session on 2025-11-15, CRISPR(CRSP) shares reached a daily high of $54.77 and a low of $48.50. At a current price of $52.57, the stock is +8.4% higher than the low and still -4.0% under the high.
Trading activity shows a volume of 4.27M, compared to an average daily volume of 2.74M.
The stock's 52-week range extends from a low of $30.04 to a high of $78.48.
The stock's 52-week range extends from a low of $30.04 to a high of $78.48.
CRSP News
On Saturday, CRISPR Therapeutics AG (NASDAQ:CRSP) shared Phase 1 data from its ongoing clinical trial evaluating CTX310, an investigational, in vivo CRISPR/Cas9...
“This has been another strong quarter of execution and progress across our portfolio,” said Samarth Kulkarni, Ph.D., Chairman and Chief Executive Officer of CRI...